Read + Share
Amedeo Smart
Independent Medical Education
Jacob J, Anami Y, High PC, Liang Z, et al. Antibody-Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Anti-Tumor Activity in Colorectal Cancer. Cancer Res 2024 Dec 18. doi: 10.1158/0008-5472.CAN-24-0798.PMID: 39693606
Email
LinkedIn
Privacy Policy